Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells

H Hagiwara1, Y Hiruma, A Inoue

  • 1Research Center for Experimental Biology, Tokyo Institute of Technology, Yokohama, Japan.

Insights

Angiotensin II (Ang II) inhibits osteoblastic bone formation and cell differentiation by interacting with the AT1 receptor. This peptide hormone reduces key markers of bone health, impacting calcium accumulation and mineralization.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Endocrinology

Background:

  • Osteoblastic cells are crucial for bone formation and remodeling.
  • Angiotensin II (Ang II) is a key hormone in the renin-angiotensin system, primarily known for its role in blood pressure regulation.
  • The specific role of Ang II in osteoblast differentiation and bone metabolism is not fully understood.

Purpose of the Study:

  • To investigate the effects of Ang II on rat calvarial osteoblastic cell differentiation.
  • To determine the impact of Ang II on bone formation by these osteoblastic cells.
  • To elucidate the receptor mechanism through which Ang II exerts its effects on osteoblasts.

Main Methods:

  • Northern blotting was used to analyze mRNA expression of osteocalcin.
  • Alkaline phosphatase activity assays were performed to assess osteoblastic differentiation.
  • Von Kossa staining and calcium quantification were employed to evaluate mineralized nodule formation.
  • Binding analysis with subtype-specific antagonists identified Ang II receptors.

Main Results:

  • Ang II significantly inhibited osteocalcin mRNA expression, a marker of osteoblastic maturation.
  • The activity of alkaline phosphatase, indicative of osteoblastic differentiation, was decreased by Ang II via the AT1 receptor.
  • Ang II reduced the formation and area of mineralized nodules, as well as cellular and matrix calcium accumulation.
  • Ang II treatment led to a marked increase in intracellular cAMP production.

Conclusions:

  • Angiotensin II (Ang II) negatively regulates key markers of osteoblastic differentiation and function.
  • The effects of Ang II on osteoblasts are mediated through the type 1 (AT1) receptor.
  • Ang II plays a significant role in osteoblastic metabolism and bone formation, warranting further investigation into its therapeutic potential or implications in bone diseases.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...